Texas Halo Fund

Profile

Texas Halo Fund is an investment company and fund series specializing in early-stage businesses, headquartered in Houston. The firm was created to give investors access to high returns from early-stage investments while addressing the usual challenges such as deal flow and due diligence. The team is comprised of managing directors with sector-specific expertise and experience in early-stage investing. They focus on constructing diversified portfolios and actively engage with management teams of their portfolio companies.

The firm invests across various industry sectors in North America. Texas Halo Fund has raised four funds, aggregating about $25 million in assets under management. These funds have invested in around sixty early-stage businesses. The investments are primarily in convertible debt and preferred stock, avoiding LLCs and certain ventures like real estate and oil and gas.

Notable portfolio companies include Quad Technologies, which was acquired by Bio-Techne; TheratomeBio, offering therapeutic preparations; TeVido BioDevices, focusing on solutions for vitiligo; and ClearCam, working within medical device technology. The fund seeks opportunities to generate high returns with manageable risk through its robust investment processes and management oversight.